Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-1013 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-103 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 |
filingDate |
2016-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2020-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2020-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-106146617-B |
titleOfInvention |
Polypeptide and application and pharmaceutical composition thereof |
abstract |
The invention relates to the technical field of polypeptide medicines, and particularly relates to a polypeptide, application thereof and a pharmaceutical composition. The polypeptide provided by the invention can inhibit the activity of WDR5 and MLL1 protein combination and the activity of MLL1 protein complex methyltransferase, thereby effectively inhibiting the growth of tumor cells and having potential biomedical development value. |
priorityDate |
2016-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |